chartexchange

NeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach

GlobeNewswire Inc. | Nov 13, 2026 8:52 AM EST

NeOnc (NASDAQ: NTHI) to present findings from 2 investigational brain cancer programs at the 31st Annual Meeting of the Society for Neuro-Oncology (SNO)

Read original article